🇺🇸 FDA

Company profile · Sponsor

Grace

Grace Therapeutics

GRCE · NYSE pharma PRINCETON, NJ, USA
Pipeline
24
Drugs
1
Patents
8

Quick answer

Grace (GRCE) is a pharma company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 1 drug, and 8 patents to this profile..

Company facts

Ticker GRCE
Exchange NYSE
Company type pharma
Headquarters PRINCETON, NJ, USA
SEC CIK 0001444192

Pipeline (24)

Search pipeline →

  1. CaPre

    Grace

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials

  2. FF/UMEC/VI

    Grace

    Asthma

    phase 3 small molecule active

    1 trial

  3. GS-100

    Grace

    NGLY1 Deficiency

    phase 3 gene therapy active

    1 trial

  4. GTX-104

    Grace

    Aneurysmal Subarachnoid Hemorrhage (aSAH)

    phase 3 small molecule active

    1 trial

  5. QVM149

    Grace

    Asthma

    phase 3 small molecule terminated

    1 trial

  6. CaPre (TM)

    Grace

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial

  7. Clonidine

    Grace

    Pregnancy Related

    phase 2 small molecule completed

    1 trial

  8. Eat Well Live Well Nutrition Program

    Grace

    Diabetes or Diabetes Prevention

    phase 2 other completed

    1 trial

  9. Ketamine

    Grace

    Obstetric Pain

    phase 2 small molecule completed

    1 trial

  10. Lipid Lowering Medication

    Grace

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial

  11. GTX-101

    Grace

    Postherpetic Neuralgia

    phase 1 small molecule active

    1 trial

  12. GTX-102 medium dose fast Period 1 and Period 2

    Grace

    Ataxia Telangiectasia

    phase 1 small molecule active

    1 trial

  13. GTX-104

    Grace

    Aneurysmal Subarachnoid Hemorrhage

    phase 1 small molecule completed

    1 trial

  14. Hydromorphone

    Grace

    Pain

    phase 1 small molecule completed

    1 trial

  15. Ketamine (Ketalar)

    Grace

    Pain

    phase 1 small molecule active

    1 trial

  16. Ketamine (Ketalar) Dose Level 1

    Grace

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  17. Desvenlafaxine Succinate

    Grace

    Vascular Depression

    approved small molecule active

    1 trial

  18. Tirzepatide

    Grace

    Prader-Willi Syndrome

    approved small molecule active

    1 trial

  19. Apolipoprotein (ApoE) detection

    Grace

    Senile Plaques

    gene therapy active

    1 trial

  20. Benralizumab

    Grace

    Asthma; Eosinophilic

    small molecule active

    1 trial

  21. Bupivacaine / fentaNYL

    Grace

    Depression, Postpartum

    small molecule completed

    1 trial

  22. ClearSight HPI Monitoring system

    Grace

    Anesthesia, Epidural

    other completed

    1 trial

  23. Control (Standard treatment)

    Grace

    Moisture Associated Skin Damage

    small molecule active

    1 trial

  24. Fospropofol (Lusedra®) 6.5

    Grace

    Interstitial Cystitis

    small molecule terminated

    1 trial

Drugs (1)

Search drugs →

  1. imiquimod

    ALDARA

    TOPICAL approved

    D06BB10

Patents (8)

Search patents →

  1. US 12414943

    Nimodipine parenteral administration

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12049487

    Universal chimeric antigen receptor T-cell preparation technique

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11840575

    Engineered immune cells targeting BCMA and their uses thereof

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11484501

    Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11478424

    Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11478420

    Vaginal probiotic products and related processes

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11291672

    Betamethasone oral spray formulation and method of use to treat ataxia

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11052029

    Cation compatible metal oxides and oral care compositions containing the metal oxides

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Grace?

Grace (GRCE) is a pharma company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 1 drug, and 8 patents to this profile..

What pipeline programs does Grace sponsor?

We track 24 ClinicalTrials.gov-linked programs for Grace, including CaPre and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Grace company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.